Original Clinical Science
Heart transplantation using allografts from older donors: Multicenter study results

https://doi.org/10.1016/j.healun.2014.10.006Get rights and content

Background

The lengthy waiting time for heart transplantation is associated with high mortality. To increase the number of donors, new strategies have emerged, including the use of hearts from donors ≥50 years old. However, this practice remains controversial. The aim of this study was to evaluate outcomes of patients receiving heart transplants from older donors.

Methods

We retrospectively analyzed 2,102 consecutive heart transplants in 8 Spanish hospitals from 1998 to 2010. Acute and overall mortality were compared in patients with grafts from donors ≥50 years old versus grafts from younger donors.

Results

There were 1,758 (84%) transplanted grafts from donors < 50 years old (Group I) and 344 (16%) from donors ≥50 years old (Group II). Group I had more male donors than Group II (71% vs 57%, p = 0.0001). The incidence of cardiovascular risk factors was higher in older donors. There were no differences in acute mortality or acute rejection episodes between the 2 groups. Global mortality was higher in Group II (rate ratio, 1.40; 95% confidence interval, 1.18–1.67; p = 0.001) than in Group I. After adjusting for donor cause of death, donor smoking history, recipient age, induction therapy, and cyclosporine therapy, the differences lost significance. Group II had a higher incidence of coronary allograft vasculopathy at 5 years (rate ratio, 1.67; 95% confidence interval, 1.22–2.27; p = 0.001).

Conclusions

There were no differences in acute and overall mortality after adjusting for confounding factors. However, there was a midterm increased risk of coronary allograft vasculopathy with the use of older donors. Careful selection of recipients and close monitoring of coronary allograft vasculopathy are warranted in these patients.

Section snippets

Methods

From January 1998 to December 2010, HTx programs at 8 centers in Spain performed 2,102 consecutive HTx surgeries. Only patients >16 years old were included in the study, and patients were divided into 2 groups according to donor age. Group I had received grafts from donors <50 years old, and Group II had received grafts from donors ≥50 years old. Patients with an additional organ transplantation or heart re-transplantation were excluded from the study.

Donor information and recipients’ clinical

Results

Overall, 1,758 (83%) recipients received grafts from donors <50 years old (Group I), and 344 (16%) recipients received grafts from donors ≥50 years old (Group II); only 18 (5%) donors were ≥60 years old. The number of transplants by year and donor age is shown in Table 1; the use of older donors has increased in recent years. There was no difference between age groups in the need for urgent HTx (27.9% in Group I vs 25.7% in Group II). Similarly, although there was a trend toward longer ischemic

Discussion

The present study is one of the largest to analyze the survival after HTx of patients with grafts from older donors, having prospectively recruited patients from 8 centers in Spain that send their data to the Spanish Register for Heart Transplantation. Our analysis indicates that donors ≥50 years old can be safely used for HTx: After adjusting for potential confounding factors, there were no differences in acute or overall mortality.

Despite the gradually increasing use of older donors, there is

Disclosure statement

The authors thank Elaine Lilly, Ph.D., for English language revision of the manuscript and to all Spanish National Register for Heart Transplantation participants.

This study was presented at the 33rd Annual Meeting and Scientific Session of the International Society for Heart and Lung Transplantation, April 24–27, 2013, Montreal, Canada.

This study was supported in part by the Spanish Network on Cardiovascular Research (RIC, Instituto Salud Carlos III, RD12/0042/000). None of the authors has a

References (32)

Cited by (0)

View full text